Variant report
Variant | nsv482221 |
---|---|
Chromosome Location | chr19:43084395-43099082 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:53)
- CpG islands (count:123)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:43097919-43098273 | A549 | lung: | n/a | chr19:43098079-43098092 chr19:43098079-43098090 |
2 | CEBPB | chr19:43097951-43098246 | HepG2 | liver: | n/a | chr19:43098079-43098092 chr19:43098079-43098090 |
3 | CEBPB | chr19:43098008-43098186 | IMR90 | lung: | n/a | chr19:43098079-43098092 chr19:43098079-43098090 |
4 | CEBPB | chr19:43097979-43098209 | K562 | blood: | n/a | chr19:43098079-43098092 chr19:43098079-43098090 |
5 | CTCF | chr19:43098920-43098983 | NHEK | skin: | n/a | n/a |
6 | CTCF | chr19:43094373-43094469 | MCF-7 | breast: | n/a | chr19:43094438-43094451 chr19:43094437-43094458 |
7 | CTCF | chr19:43098921-43098989 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr19:43098900-43099050 | Caco-2 | colon: | n/a | n/a |
9 | CTCF | chr19:43098881-43099034 | GM12891 | blood: | n/a | n/a |
10 | CTCF | chr19:43094320-43094470 | HepG2 | liver: | n/a | chr19:43094438-43094451 chr19:43094437-43094458 |
11 | CTCF | chr19:43098840-43099095 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | CTCF | chr19:43098903-43098999 | K562 | blood: | n/a | n/a |
13 | CTCF | chr19:43097820-43097970 | SAEC | small airway: | n/a | n/a |
14 | CTCF | chr19:43098932-43099001 | GM19238 | blood: | n/a | n/a |
15 | CTCF | chr19:43098888-43099051 | MCF-7 | breast: | n/a | n/a |
16 | CTCF | chr19:43098840-43098990 | GM06990 | blood: | n/a | n/a |
17 | CTCF | chr19:43094420-43094570 | HEK293 | kidney: | n/a | chr19:43094438-43094451 chr19:43094437-43094458 |
18 | CTCF | chr19:43098900-43099050 | K562 | blood: | n/a | n/a |
19 | CTCF | chr19:43098840-43098990 | A549 | lung: | n/a | n/a |
20 | CTCF | chr19:43098920-43099005 | HepG2 | liver: | n/a | n/a |
21 | CTCF | chr19:43098882-43099020 | MCF-7 | breast: | n/a | n/a |
22 | CTCF | chr19:43094460-43094610 | A549 | lung: | n/a | n/a |
23 | CTCF | chr19:43098887-43099031 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr19:43098880-43099030 | HepG2 | liver: | n/a | n/a |
25 | CTCF | chr19:43094386-43094425 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | CTCF | chr19:43098820-43098970 | WERI-Rb-1 | eye: | n/a | n/a |
27 | CTCF | chr19:43098820-43098970 | HEK293 | kidney: | n/a | n/a |
28 | CTCF | chr19:43098860-43099010 | GM12865 | blood: | n/a | n/a |
29 | CTCF | chr19:43094393-43094475 | MCF-7 | breast: | n/a | chr19:43094438-43094451 chr19:43094437-43094458 |
30 | CTCF | chr19:43094356-43094492 | MCF-7 | breast: | n/a | chr19:43094438-43094451 chr19:43094437-43094458 |
31 | CTCF | chr19:43098827-43099048 | HepG2 | liver: | n/a | n/a |
32 | CTCF | chr19:43098883-43099054 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | CTCF | chr19:43098840-43098990 | WERI-Rb-1 | eye: | n/a | n/a |
34 | CTCF | chr19:43098907-43098989 | MCF-7 | breast: | n/a | n/a |
35 | CTCF | chr19:43098660-43098810 | SAEC | small airway: | n/a | n/a |
36 | CTCF | chr19:43098917-43099007 | MCF-7 | breast: | n/a | n/a |
37 | CTCF | chr19:43098926-43098965 | GM12892 | blood: | n/a | n/a |
38 | EBF1 | chr19:43088514-43088635 | GM12878 | blood: | n/a | n/a |
39 | JUND | chr19:43093156-43093358 | HepG2 | liver: | n/a | chr19:43093216-43093225 |
40 | POLR2A | chr19:43092168-43092182 | MCF-7 | breast: | n/a | n/a |
41 | POLR2A | chr19:43093554-43093820 | MCF-7 | breast: | n/a | n/a |
42 | POLR2A | chr19:43092140-43092150 | MCF-7 | breast: | n/a | n/a |
43 | RAD21 | chr19:43098736-43099050 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | RAD21 | chr19:43098860-43099051 | HepG2 | liver: | n/a | n/a |
45 | RAD21 | chr19:43098942-43098989 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | SPI1 | chr19:43091049-43091445 | HL-60 | blood: | n/a | n/a |
47 | SPI1 | chr19:43095428-43095802 | HL-60 | blood: | n/a | chr19:43095562-43095569 |
48 | TCF7L2 | chr19:43092327-43092363 | Hela-S3 | cervix: | n/a | n/a |
49 | USF2 | chr19:43098375-43098425 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | USF2 | chr19:43096272-43096282 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43099046-43099096 | HAEpiC | amniotic membrane: | n/a |
2 | chr19:43099046-43099096 | HAEpiC | amniotic membrane: | n/a |
3 | chr19:43099046-43099096 | Hepatocyte | liver: | n/a |
4 | chr19:43099046-43099096 | BE2_C | brain: | n/a |
5 | chr19:43099046-43099096 | HRCEpiC | kidney: | n/a |
6 | chr19:43099046-43099096 | ovcar-3 | ovarian: | n/a |
7 | chr19:43085416-43085466 | A549 | lung: | n/a |
8 | chr19:43085416-43085466 | NHDF-neo | bronchial: | n/a |
9 | chr19:43085416-43085466 | PANC-1 | pancreas: | n/a |
10 | chr19:43085416-43085466 | HRE | kidney: | n/a |
11 | chr19:43099046-43099096 | HCT-116 | colon: | n/a |
12 | chr19:43099046-43099096 | LNCaP | prostate: | n/a |
13 | chr19:43099046-43099096 | MCF-7 | breast: | n/a |
14 | chr19:43085416-43085466 | HRCEpiC | kidney: | n/a |
15 | chr19:43099046-43099096 | IMR90 | lung: | fetal |
16 | chr19:43085416-43085466 | H1-hESC | embryonic stem cell: | embryo |
17 | chr19:43099046-43099096 | HCM | heart: | n/a |
18 | chr19:43085416-43085466 | BE2_C | brain: | n/a |
19 | chr19:43099046-43099096 | Hela-S3 | cervix: | n/a |
20 | chr19:43085416-43085466 | AG04450 | lung: | fetal |
21 | chr19:43099046-43099096 | H1-hESC | embryonic stem cell: | embryo |
22 | chr19:43099046-43099096 | HPAEpiC | pulmonary alveolar: | n/a |
23 | chr19:43099046-43099096 | NT2-D1 | testis: | n/a |
24 | chr19:43099046-43099096 | SK-N-SH | brain: | n/a |
25 | chr19:43085416-43085466 | HL-60 | blood: | n/a |
26 | chr19:43085416-43085466 | ECC-1 | luminal epithelium: | n/a |
27 | chr19:43085416-43085466 | U87 | brain: | n/a |
28 | chr19:43099046-43099096 | HUVEC | blood vessel: | n/a |
29 | chr19:43085416-43085466 | GM12892 | blood: | n/a |
30 | chr19:43085416-43085466 | RPTEC | kidney: | n/a |
31 | chr19:43099046-43099096 | BJ | skin: | n/a |
32 | chr19:43085416-43085466 | AG04449 | skin: | fetal |
33 | chr19:43099046-43099096 | SKMC | muscle: | n/a |
34 | chr19:43085416-43085466 | GM19239 | blood: | n/a |
35 | chr19:43085416-43085466 | ProgFib | skin: | n/a |
36 | chr19:43099046-43099096 | AG10803 | skin: | n/a |
37 | chr19:43085416-43085466 | GM12878 | blood: | n/a |
38 | chr19:43099046-43099096 | AG04449 | skin: | fetal |
39 | chr19:43085416-43085466 | HCM | heart: | n/a |
40 | chr19:43099046-43099096 | ECC-1 | luminal epithelium: | n/a |
41 | chr19:43099046-43099096 | RPTEC | kidney: | n/a |
42 | chr19:43099046-43099096 | NHBE | bronchial: | n/a |
43 | chr19:43085416-43085466 | GM06990 | blood: | n/a |
44 | chr19:43099046-43099096 | AoSMC | blood vessel: | n/a |
45 | chr19:43099046-43099096 | HEEpiC | esophagus: | n/a |
46 | chr19:43085416-43085466 | HepG2 | liver: | n/a |
47 | chr19:43099046-43099096 | HRE | kidney: | n/a |
48 | chr19:43099046-43099096 | HEK293 | kidney: | embryo |
49 | chr19:43099046-43099096 | SAEC | small airway: | n/a |
50 | chr19:43099046-43099096 | HMEC | breast: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEACAM8 | TF binding region |
CEACAM8 | CpG island |
ENSG00000124469 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184895640 | chr19:43084406-43084407 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564680114 | chr19:43084408-43084409 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527302962 | chr19:43084430-43084431 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189408163 | chr19:43084475-43084476 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139996497 | chr19:43084481-43084482 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374171388 | chr19:43084546-43084547 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529765618 | chr19:43084579-43084580 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549560814 | chr19:43084604-43084605 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143477715 | chr19:43084616-43084617 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117250901 | chr19:43084617-43084618 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374324883 | chr19:43084669-43084670 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558815581 | chr19:43084677-43084678 | Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs45513692 | chr19:43084769-43084770 | Genic enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs367947323 | chr19:43084804-43084805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62112065 | chr19:43084816-43084817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577498643 | chr19:43084823-43084824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538561610 | chr19:43084834-43084835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535005553 | chr19:43084864-43084865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547474686 | chr19:43084877-43084878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145571453 | chr19:43084961-43084962 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574875078 | chr19:43084962-43084963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148443621 | chr19:43084971-43084972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557548650 | chr19:43085020-43085021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373906867 | chr19:43085057-43085058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577518258 | chr19:43085074-43085075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546492886 | chr19:43085080-43085081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557088455 | chr19:43085089-43085090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560009513 | chr19:43085096-43085097 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528817099 | chr19:43085140-43085141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560120961 | chr19:43085163-43085164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540998902 | chr19:43085205-43085206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34985857 | chr19:43085231-43085232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200413035 | chr19:43085232-43085233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371566730 | chr19:43085288-43085289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560765944 | chr19:43085332-43085333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529728761 | chr19:43085352-43085353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181016676 | chr19:43085375-43085376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs45551231 | chr19:43085376-43085377 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs532193168 | chr19:43085479-43085480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374102000 | chr19:43085633-43085634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565945389 | chr19:43085685-43085686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534659862 | chr19:43085709-43085710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548555219 | chr19:43085770-43085771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142575798 | chr19:43085775-43085776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs367682592 | chr19:43085786-43085787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371401725 | chr19:43085808-43085809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557514060 | chr19:43085867-43085868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185297005 | chr19:43085903-43085904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540022019 | chr19:43085935-43085936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553318149 | chr19:43086019-43086020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:43081400-43100600 | Weak transcription | Spleen | Spleen |
2 | chr19:43084200-43084800 | Genic enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr19:43084800-43085400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr19:43085400-43086200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
5 | chr19:43086200-43088000 | Genic enhancers | Primary neutrophils fromperipheralblood | blood |
6 | chr19:43088000-43092200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
7 | chr19:43088400-43088800 | Bivalent Enhancer | Primary B cells from cord blood | blood |
8 | chr19:43088400-43089400 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr19:43088800-43089400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr19:43090200-43091200 | Bivalent Enhancer | Primary B cells from cord blood | blood |
11 | chr19:43092200-43094400 | Genic enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr19:43094200-43094400 | Enhancers | Primary B cells from cord blood | blood |
13 | chr19:43094400-43095400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
14 | chr19:43094400-43100200 | Weak transcription | Primary B cells from cord blood | blood |
15 | chr19:43095400-43096400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
16 | chr19:43096400-43096800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
17 | chr19:43096800-43097400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
18 | chr19:43096800-43099000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
19 | chr19:43097400-43097800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
20 | chr19:43097800-43099200 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |